Merck & Co’s LAVA Therapeutics LVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.52M Hold
1,149,345
0.7% 8
2025
Q1
$1.46M Hold
1,149,345
0.89% 8
2024
Q4
$1.09M Buy
+1,149,345
New +$1.09M 0.42% 10